QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 30 July 2008
doi: 10.1242/dev.017863

This Article Figures Only Full Text Full Text (PDF) Supplementary Material All Versions of this Article: dev.017863v1 135/17/2981    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by El-Bizri, N. Articles by Rabinovitch, M. Search for Related Content PubMed PubMed Citation Articles by El-Bizri, N. Articles by Rabinovitch, M. Social Bookmarking                         What's this?

SM22-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac and vascular development, and influences organogenesis

¹ Cardiopulmonary Research Program, Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University School of Medicine, Stanford, California, CA XXXXX?, USA.
² Department of Pediatrics, Stanford University School of Medicine, Stanford, California, CA XXXXX?, USA.
³ Department of Medicine, Stanford University School of Medicine, Stanford, California, CA XXXXX?, USA.
⁴ Molecular Developmental Biology Group, Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, NC XXXXX?, USA.

^* Author for correspondence (e-mail: marlener{at}stanford.edu)

Accepted 2 July 2008

Expression of bone morphogenetic protein receptor 1A (BMPR1A) is attenuated in the lung vessels of patients with pulmonary arterial hypertension, but the functional impact of this abnormality is unknown. We ablated Bmpr1a in cardiomyocytes and vascular smooth muscle cells (VSMCs) by breeding mice possessing a loxP allele of Bmpr1a (Bmpr1a^flox) expressing R26R with SM22-Cre mice. SM22-Cre;R26R;Bmpr1a^flox/flox mice died soon after embryonic day 11 (E11) with massive vascular and pericardial hemorrhage and impaired brain development. At E10.5, SM22-Cre;R26R;Bmpr1a^flox/flox embryos showed thinning of the myocardium associated with reduced cell proliferation. These embryos also had severe dilatation of the aorta and large vessels with impaired investment of SMCs that was also related to reduced proliferation. SM22-Cre;R26R;Bmpr1a^flox/flox mice showed collapsed telencephalon in association with impaired clearing of brain microvessels in areas where reduced apoptosis was observed. Transcript and protein levels of matrix metalloproteinase (MMP) 2 and 9 were reduced in E9.5 and E10.5 SM22-Cre;R26R;Bmpr1a^flox/flox embryos, respectively. Knock-down of BMPR1A by RNA interference in human pulmonary artery SMCs reduced MMP2 and MMP9 activity, attenuated serum-induced proliferation, and impaired PDGF-BB-directed migration. RNA interference of MMP2 or MMP9 recapitulated these abnormalities, supporting a functional interaction between BMP signaling and MMP expression. In human brain microvascular pericytes, knock-down of BMPR1A reduced MMP2 activity and knock-down of either BMPR1A or MMP2 caused resistance to apoptosis. Thus, loss of Bmpr1a, by decreasing MMP2 and/or MMP9 activity, can account for vascular dilatation and persistence of brain microvessels, leading to the impaired organogenesis documented in the brain.

Key words: Bmpr1a (Alk3), Vasculogenesis, Heart development, Craniofacial development, Matrix metalloproteinase (metallopeptidase), MMP2, MMP9, Smooth muscle cell proliferation, Pericyte apoptosis, SM22 (transgelin, Tagln), Mouse

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?